December 10, 2019
The University of North Carolina Lineberger Comprehensive Cancer Center’s annual scientific retreat drew more than 230 staff and researchers to address a key initiative that seeks to engage the community in the center’s research, care and policy work to best meet the needs of cancer patients in North Carolina and beyond. This year’s meeting focused …
December 6, 2019
A University of North Carolina Lineberger Comprehensive Cancer Center researcher predicts an e-cigarette marketing trend could lead more people to try vaping products, including teens and younger people. In an industry watch update published in the journal Tobacco Control, Rebecca S. Williams, PhD, MHS, reported on the resurgence of cheap, disposable e-cigarettes that are easily …
December 6, 2019
University of North Carolina Lineberger Comprehensive Cancer Center researchers will be well-represented at the 61st American Society of Hematology Annual Meeting in Orlando, Florida, Dec. 7-10. ASH is the world’s largest professional society of hematologists and is dedicated to understanding, diagnosing, treating and preventing blood disorders. The society expects more than 20,000 hematologists and health …
December 5, 2019
A multidisciplinary team of investigators, including from the University of North Carolina Lineberger Comprehensive Cancer Center, the Vanderbilt University Medical Center, King’s College and the University of California, San Francisco, has discovered how mouth stem cells may uniquely be equipped to help improve healing in other parts of the body after disease or injury. The …
December 5, 2019
UNC Lineberger’s Comprehensive Cancer Support Program offers free wellness workshops to help adult cancer survivors transition from active treatment. Through Cancer Transitions, cancer survivors can learn about nutrition, exercise, coping with stress, and medical management from UNC Lineberger experts. Cancer Transitions is a program of the Cancer Support Community and LiveSTRONG. “After treatment ends, survivors …
December 2, 2019
The North Carolina Biotechnology Center awarded $100,000 to UNC Lineberger Comprehensive Cancer Center’s Chad Pecot, MD, to study an experimental treatment that would silence a gene commonly mutated in cancer. Using a Nobel Prize-winning technology called RNA interference or RNAi, Pecot’s lab designed an investigational drug to shut down the mutated version of the KRAS …
December 1, 2019
The Web of Science Group’s 2019 Highly Cited Researchers list recognized 18 UNC Lineberger members for being among the world’s most influential researchers of the past decade. The listing is limited to researchers who have published multiple highly-cited papers that rank in the top 1 percent by citations for field and year. Approximately only 6,200 …
November 26, 2019
A group from the Coldwell Banker Howard Perry and Walston real estate agency presented a $42,000 donation to UNC Lineberger to support its Comprehensive Cancer Support Program at the North Carolina Cancer Hospital. HPW raised the funds during its 2019 Pig Out For The Cure event in September. Pig Out For The Cure is an …
November 18, 2019
The KRAS gene is commonly mutated in cancer. In the journal Cancer Discovery, researchers led by Channing Der, PhD, and Aaron Hobbs, PhD, reported details of the role of the KRAS G12R mutation in pancreatic cancer, and therapeutic strategies that might work for this mutation type. By studying unique differences in DNA mutations within the same gene, researchers are working to uncover the mutation-specific mechanisms that drive cancerous growth.
November 14, 2019
The North Carolina Cancer Hospital, the clinical home of UNC Lineberger Comprehensive Cancer Center, has named the multidisciplinary clinic reception area in honor of Karen Isner, a two-time cancer survivor and the mother of professional tennis player John Isner.
